Cargando…
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Neurological and neurodegenerative diseases are debilitating conditions, and frequently lack an effective treatment. Monoacylglycerol lipase (MAGL) is a key enzyme involved in the metabolism of 2-AG (2-arachidonoylglycerol), a neuroprotective endocannabinoid intimately linked to the generation of pr...
Autores principales: | Zanfirescu, Anca, Ungurianu, Anca, Mihai, Dragos Paul, Radulescu, Denise, Nitulescu, George Mihai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468992/ https://www.ncbi.nlm.nih.gov/pubmed/34577139 http://dx.doi.org/10.3390/molecules26185668 |
Ejemplares similares
-
Cetirizine and Levetiracetam as Inhibitors of Monoacylglycerol Lipase: Investigating Their Repurposing Potential as Novel Osteoarthritic Pain Therapies
por: Andrei, Corina, et al.
Publicado: (2023) -
Molecular Docking and Screening Studies of New Natural Sortase A Inhibitors
por: Nitulescu, Georgiana, et al.
Publicado: (2017) -
Identifying FAAH Inhibitors as New Therapeutic Options for the Treatment of Chronic Pain through Drug Repurposing
por: Zanfirescu, Anca, et al.
Publicado: (2021) -
Candidates for Repurposing as Anti-Virulence Agents Based on the Structural Profile Analysis of Microbial Collagenase Inhibitors
por: Nitulescu, Georgiana, et al.
Publicado: (2021) -
Vitamin E beyond Its Antioxidant Label
por: Ungurianu, Anca, et al.
Publicado: (2021)